Cleared Traditional

K831416 - EMIT QST TOBRAMYCIN ASSAY

K831416 is the FDA 510(k) clearance for EMIT QST TOBRAMYCIN ASSAY by Syva Co.. It is a Class 2 Toxicology device (product code LCD) cleared through the Traditional 510(k) pathway after a 36-day FDA review.

K831416 · Syva Co. · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1983
Decision
36d
Days
Class 2
Risk

K831416 is an FDA 510(k) clearance for the EMIT QST TOBRAMYCIN ASSAY. Classified as Enzyme Immunoassay, Gentamicin (product code LCD), Class II - Special Controls.

Submitted by Syva Co. (Mchenry, US). The FDA issued a Cleared decision on June 8, 1983 after a review of 36 days - a notably fast clearance cycle.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3450 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Syva Co. devices

Submission Details

510(k) Number K831416 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 03, 1983
Decision Date June 08, 1983
Days to Decision 36 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
51d faster than avg
Panel avg: 87d · This submission: 36d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LCD Enzyme Immunoassay, Gentamicin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3450
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Peers - LCD Enzyme Immunoassay, Gentamicin

All 30
Devices cleared under the same product code (LCD) and FDA review panel - the closest regulatory comparables to K831416.
DU PONT GENTAMICIN ASSAY REAGENTS
K850060 · E.I. Dupont DE Nemours & Co., Inc. · Jan 1985
STRATUS GENTAMICIN FLUOROMETRIC ENZYM
K832445 · American Dade · Aug 1983
EMIT AMD GENTAMICIN ASSAY
K832056 · Syva Co. · Aug 1983
EMIT QST GENTAMICIN ASSAY
K831304 · Syva Co. · Jun 1983
SOPHEIA GENTAMICIN EIA KIT
K823387 · Diagnostic Products Corp. · Dec 1982
GENTAMICIN REAGENT TEST KIT
K811692 · Beckman Instruments, Inc. · Jul 1981